Servicio Nacional de Sanidad y Calidad Agroalimentaria (SENASA), Avda. Fleming 1653, 1640 Martínez, Argentina.
Centro de Virología Animal, Instituto de Ciencia y Tecnología Dr. César Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Saladillo 2468, 1440 Buenos Aires, Argentina.
Vet Microbiol. 2013 Mar 23;162(2-4):479-490. doi: 10.1016/j.vetmic.2012.10.035. Epub 2012 Nov 7.
Molecular, antigenic and vaccine matching studies, including protective response in vivo, were conducted with a foot-and-mouth disease type O virus isolated during the outbreak in September 2011 in San Pedro, Paraguay, country internationally recognized as free with vaccination in 1997. The phylogenetic tree derived from complete VP(1) sequences as well as monoclonal antibody profiling indicated that this isolate was related to viruses responsible for previous emergencies in free areas of the Southern Cone of South America occurring sporadically between the years 2000 and 2006. Marked differences with the vaccine strain O(1)/Campos, including the loss of reactivity with neutralizing MAbs, were recognized. Levels of protective antibodies induced by the vaccine containing the O(1)/Campos strain against the San Pedro virus and the virus responsible for the previous emergency in 2006 in the Southern Cone assessed by in vitro vaccine matching studies pointed to an insufficient protective response 30 days after vaccination (DPV), which was properly attained at 79 DPV or after revaccination. In agreement with the in vitro assessment, the in vivo challenge in the Protection against Podal Generalization test in cattle indicated appropriate protection for the San Pedro strain at 79 DPV or after revaccination. The complementary conclusions that can be derived from vaccine matching tests designed differently to fit the various objectives intended: prophylaxis, emergency vaccination or incorporation of new field strains into antigen banks, is evaluated. This is the first report of the antigenic and immunogenic characterization of the variants responsible for emergencies in the Southern Cone of South America and the putative impact of the changes on the cross protection conferred by the vaccine strain.
对 2011 年 9 月巴拉圭圣佩德罗口蹄疫疫情中分离到的 O 型口蹄疫病毒进行了分子、抗原和疫苗匹配研究,包括体内保护反应。该国于 1997 年在国际上被认可为无疫苗接种区,自那时以来一直保持无疫状态。从完整 VP(1)序列得出的系统发育树以及单克隆抗体分析表明,该分离株与导致 2000 年至 2006 年期间南美南部锥体自由地区间歇性发生的先前紧急情况的病毒有关。与疫苗株 O(1)/坎波斯株相比,发现明显的差异,包括中和单抗反应性丧失。疫苗匹配研究评估了含有 O(1)/坎波斯株的疫苗对圣佩德罗病毒和 2006 年在南锥体发生的先前紧急情况病毒的免疫保护抗体水平,结果表明,在接种疫苗后 30 天(DPV)时保护反应不足,在 79 DPV 或重新接种后才能获得适当的保护反应。与体外评估一致,牛的足底全面保护试验中的体内攻毒试验表明,圣佩德罗株在 79 DPV 或重新接种后具有适当的保护作用。可以从设计目的不同的疫苗匹配试验中得出不同的结论,以适应不同的目标:预防、紧急接种或将新的田间株纳入抗原库。这是首次报道导致南美南部锥体紧急情况的变异株的抗原性和免疫原性特征,以及这些变化对疫苗株提供的交叉保护的潜在影响。